AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atkinson, C.
Right arrow Articles by Schwartz, S. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkinson, C.
Right arrow Articles by Schwartz, S. M
Agricola
Right arrow Articles by Atkinson, C.
Right arrow Articles by Schwartz, S. M
American Journal of Clinical Nutrition, Vol. 84, No. 3, 587-593, September 2006
© 2006 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States 1,2,3

Charlotte Atkinson, Johanna W Lampe, Delia Scholes, Chu Chen, Kristiina Wähälä and Stephen M Schwartz

1 From the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA (CA, JWL, CC, and SMS); the Department of Epidemiology, University of Washington, Seattle, WA (JWL, DS, CC, and SMS); the Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, WA (DS); and the University of Helsinki, Helsinki, Finland (KW).

Background: Uterine fibroids are hormonally responsive; estradiol and progesterone stimulate their growth, and gonadotrophin-releasing hormone agonists shrink them. Phytoestrogens, including isoflavones and lignans, can act as weak estrogens or antiestrogens.

Objective: The objective of this case-control study was to evaluate the relation between uterine fibroid risk and phytoestrogen exposure.

Design: Two overnight urine collections (48 h apart) from 170 uterine fibroid cases and 173 controls were analyzed for isoflavonoids (ie, daidzein, genistein, equol, and O-desmethylangolensin) and lignans (enterodiol and enterolactone). Logistic regression was used to determine associations between the mean excretion of the 2 collections and the risk of uterine fibroids.

Results: Unadjusted isoflavone excretion did not differ significantly between cases and controls (2.33 ± 5.82 and 2.60 ± 5.90 nmol/mg Cr, respectively; P = 0.68), but cases excreted significantly less lignans than did controls (2.86 ± 3.45 and 4.57 ± 6.67 nmol/mg Cr, respectively; P < 0.01). The trend for a reduced risk of uterine fibroids with increasing quartiles of lignan excretion was significant (odds ratio for highest versus lowest quartile = 0.31; 95% CI: 0.17, 0.58; P for trend < 0.01). When adjusted for age, BMI, race, family history of uterine fibroids, and isoflavone excretion, this trend remained but was attenuated (P = 0.07).

Conclusions: Our findings suggest a modest inverse association between lignan excretion and uterine fibroid risk. Whether this relation represents an effect of lignans per se or of other constituents of lignan-containing foods on the development of uterine fibroids remains to be determined. No association was found between isoflavone excretion and uterine fibroids; however, the intake of soy foods, the primary source of isoflavones, was low in this population.

Key Words: Isoflavone • leiomyomata • lignan • phytoestrogen • uterine fibroid • women






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition